How to Slow Down Liver Fibrosis | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Surprising Nutritional Support for Hepatitis C Patients

Back to News Homepage
Next

Is Gluten Harmful to Those with Hepatitis C?

How to Slow Down Liver Fibrosis

The Editors at Hepatitis Central
February 10, 2015

Print this page

Discover two ways to slow the advancement of liver fibrosis in patients with HCV.
How to Slow Down Liver Fibrosis Pin it on Pinterest

Strategies for Slowing the Progression of Liver Fibrosis in Hepatitis C

By Michael R. Page, PharmD, RPh

February 06, 2015

In 2 recent studies, statins and aspirin have been associated with lower rates of progression of liver fibrosis in patients with hepatitis C. Strategies for slowing the rate of progression of liver fibrosis are important for these reasons: (1) the high cost of treatment for hepatitis C; and (2) updated guidelines that recommend prioritizing treatment to sicker patients and postponing treatment in other groups.1-4

Statins
In animal models, statins have been shown to slow the progression of hepatic fibrosis, but this finding has only recently been evaluated in humans. Using data from the HALT-C trial, researchers Simon et al examined the relationship between statin use and changes in liver fibrosis scores.3

Continue reading this entire article:
http://www.hcplive.com/publications/targeted-therapies-hepatitis-c/2014/October2014/Strategies-for-Slowing-the-Progression-of-Liver-Fibrosis-in-Hepatitis-C-

5 Comments
Share
Share
Previous

Surprising Nutritional Support for Hepatitis C Patients

Back to News Homepage
Next

Is Gluten Harmful to Those with Hepatitis C?

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.